Literature DB >> 28932596

Examining the ınterval between radiation therapy and surgery in trimodality therapy: Try Tri Again.

Sarah J Gao1, Anthony W Kim2.   

Abstract

Year:  2017        PMID： 28932596      PMCID： PMC5594177          DOI： 10.21037/jtd.2017.07.17

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.

Authors:  Michael Thomas; Christian Rübe; Petra Hoffknecht; Hans N Macha; Lutz Freitag; Albert Linder; Norman Willich; Michael Hamm; Gerhard W Sybrecht; Dieter Ukena; Karl-Matthias Deppermann; Cornelia Dröge; Dorothea Riesenbeck; Achim Heinecke; Cristina Sauerland; Klaus Junker; Wolfgang E Berdel; Michael Semik
Journal:  Lancet Oncol       Date:  2008-06-24       Impact factor: 41.316

2.  Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.

Authors:  Matthew Koshy; Stacey A Fedewa; Renu Malik; Mark K Ferguson; Wickii T Vigneswaran; Lawrence Feldman; Andrew Howard; Khaled Abdelhady; Ralph R Weichselbaum; Katherine S Virgo
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

3.  Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy.

Authors:  T I Lingos; A Recht; F Vicini; A Abner; B Silver; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

4.  Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow.

Authors:  Neil D Theise; Octavian Henegariu; Joanna Grove; Jayishree Jagirdar; Peter N Kao; James M Crawford; Sunil Badve; Romil Saxena; Diane S Krause
Journal:  Exp Hematol       Date:  2002-11       Impact factor: 3.084

5.  Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Sarah J Gao; Christopher D Corso; Elyn H Wang; Justin D Blasberg; Frank C Detterbeck; Daniel J Boffa; Roy H Decker; Anthony W Kim
Journal:  J Thorac Oncol       Date:  2016-10-05       Impact factor: 15.609

6.  The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.

Authors:  Patti A Groome; Vanessa Bolejack; John J Crowley; Catherine Kennedy; Mark Krasnik; Leslie H Sobin; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

7.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

8.  Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer.

Authors:  Sibu P Saha; Rohan J Kalathiya; Daniel L Davenport; Victor A Ferraris; Timothy W Mullett; Joseph B Zwischenberger
Journal:  Oman Med J       Date:  2014-01

Review 9.  Neoadjuvant Therapy in Non-Small Cell Lung Cancer.

Authors:  Yifan Zheng; Michael T Jaklitsch; Raphael Bueno
Journal:  Surg Oncol Clin N Am       Date:  2016-07       Impact factor: 3.495

10.  Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Authors:  Godehard Friedel; Wilfried Budach; Juergen Dippon; Werner Spengler; Susanne Martina Eschmann; Christina Pfannenberg; Fawaz Al-Kamash; Thorsten Walles; Hermann Aebert; Thomas Kyriss; Stefanie Veit; Martin Kimmich; Michael Bamberg; Martin Kohlhaeufl; Volker Steger; Thomas Hehr
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.